BEVESPI AEROSPHERE

Peak

glycopyrrolate and formoterol fumarate

NDAINHALATIONAEROSOL, METERED
Approved
Apr 2016
Lifecycle
Peak
Competitive Pressure
0/100

Mechanism of Action

fumarate. The mechanism of action described below for the individual components applies to BEVESPI AEROSPHERE. These drugs represent two different classes of medications (an anticholinergic, and a long-acting selective beta 2 -adrenoceptor agonist) that have different effects on clinical physiology…

Loss of Exclusivity

LOE Date
Mar 17, 2031
61 months away
Patent Expiry
Mar 17, 2031

Patent Records (5)

Patent #ExpiryTypeUse Code
8808713
May 28, 2030
Product
U-2889
8324266
May 28, 2030
U-2889
8703806
May 28, 2030
U-2889
10716753
May 28, 2030
Product
U-2889
9463161
May 28, 2030
Product
U-2889